Cargando…
CAR‐NK cells from engineered pluripotent stem cells: Off‐the‐shelf therapeutics for all patients
Clinical success of adoptive cell therapy with chimeric antigen receptor (CAR) T cells for treating hematological malignancies has revolutionized the field of cellular immunotherapy. However, due to the nature of utilizing autologous T cells, affordability and availability are major hurdles, in addi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560199/ https://www.ncbi.nlm.nih.gov/pubmed/34724715 http://dx.doi.org/10.1002/sctm.21-0135 |